Frank is a Partner with STARTech Early Ventures, a seed-stage venture capital firm. He is responsible for managing the medical technology and healthcare investment activity at STARTech.

While serving as the healthcare/medical technology partner at STARTech, Frank has been active as an independent management and business strategy advisor and interim executive focusing on startup and turnaround engagements. Recent assignments have included interim CEO of Endothelix, Inc. and CFO of Reata Pharmaceuticals, Inc.

Frank’s career includes positions as President of a contract manufacturing company serving the telecommunications, medical, and consumer goods marketplaces; Operations Vice President of a medical device manufacturer with operations in the US and UK; and General Manager of the biomedical business unit of McGaw, Inc.

Frank is a member of the Texas Higher Education Coordinating Board’s (THECB) Advisory Committee of Research Projects (ACORP), a member of the Board of Directors of BIODFW, and a member of the Board of Directors of the Dallas-Fort Worth Health Industry Council.
Frank Gerome holds a BS degree from the University of Southern California and an MBA from Pepperdine University. He served as an officer in United States Navy following graduation from college.